BPGAM
HZNP

BTG Pactual Global Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

BTG Pactual Global Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-57,907
Closed -$6.7M – 81
2023
Q3 		$6.7M Buy
57,907
+17,200
+42% +$1.85M 1.51% 16
2023
Q2 		$4.19M Buy
40,707
+9,105
+29% +$961K 0.89% 32
2023
Q1 		$3.45M Buy
+31,602
New +$3.49M 1.32% 13

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BTG Pactual Global Asset Management's HZNP Position: Q4 2023 in Review

BTG Pactual Global Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 57,907 shares — an estimated $6.7M sold.

BTG Pactual Global Asset Management first reported a position in HZNP in Q1 2023 and held it in 3 quarters. The position peaked at $6.7M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • BTG Pactual Global Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 57,907 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $6.7M.
  • BTG Pactual Global Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023 and held it in 3 quarters.
  • BTG Pactual Global Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.7M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.